These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31279693)

  • 1. Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury.
    Zhang ZY; Li J; Ye Q; Dong Y; Bao GM; Shen YK; Weng JF; Luo LF; Cen M
    Clin Chim Acta; 2019 Oct; 497():6-12. PubMed ID: 31279693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ST2 as a potential prognostic biomarker for traumatic brain injury.
    Du Q; Weng JF; Luo LF; Cen M; Yu WH; Zheng YK; Hu W; Pan JW; Dong XQ
    Clin Chim Acta; 2018 Dec; 487():145-152. PubMed ID: 30266513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of serum translocator protein in patients with traumatic brain injury.
    Luo LF; Weng JF; Cen M; Dong XQ; Yu WH; Du Q; Yang DB; Zheng YK; Hu W; Yu L; Luo SD
    Clin Chim Acta; 2019 Jan; 488():25-30. PubMed ID: 30385279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury.
    Yang DB; Yu WH; Dong XQ; Zhang ZY; Du Q; Zhu Q; Che ZH; Wang H; Shen YF; Jiang L
    Clin Chim Acta; 2017 Jun; 469():99-104. PubMed ID: 28366792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum S100A12 as a prognostic biomarker of severe traumatic brain injury.
    Feng MJ; Ning WB; Wang W; Lv ZH; Liu XB; Zhu Y; Gao W; Jin HZ; Gao SS
    Clin Chim Acta; 2018 May; 480():84-91. PubMed ID: 29408171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH; Hwang SK
    World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
    Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP
    Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of plasma nesfatin-1 concentrations in patients with traumatic brain injury.
    Wu GQ; Chou XM; Ji WJ; Yang XG; Lan LX; Sheng YJ; Shen YF; Li JR; Huang GZ; Yu WH; Dong XQ; Du Q; Yang DB; Zhang ZY; Wang H; Shen YF; Jiang L
    Clin Chim Acta; 2016 Jul; 458():124-8. PubMed ID: 27155585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
    Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
    J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the performances of copeptin and multiple biomarkers in long-term prognosis of severe traumatic brain injury.
    Zhang ZY; Zhang LX; Dong XQ; Yu WH; Du Q; Yang DB; Shen YF; Wang H; Zhu Q; Che ZH; Liu QJ; Jiang L; Du YF
    Peptides; 2014 Oct; 60():13-7. PubMed ID: 25076464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum thioredoxin and in-hospital major adverse events after traumatic brain injury.
    Dong XQ; Yu WH; Zhang ZY; Yang DB; Du Q; Wang H; Shen YF; Jiang L; Che ZH; Zhu Q
    Clin Chim Acta; 2017 Jun; 469():75-80. PubMed ID: 28347674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and Diagnostic Utility of Serum Biomarkers in Pediatric Traumatic Brain Injury.
    Munoz Pareja JC; de Rivero Vaccari JP; Chavez MM; Kerrigan M; Pringle C; Guthrie K; Swaby K; Coto J; Kobeissy F; Avery KL; Ghosh S; Dhanashree R; Shanmugham P; Lautenslager LA; Faulkenberry S; Pareja Zabala MC; Al Fakhri N; Loor-Torres R; Governale LS; Blatt JE; Gober J; Perez PK; Solano J; McCrea H; Thorson C; O'Phelan KH; Keane RW; Dietrich WD; Wang KK
    J Neurotrauma; 2024 Jan; 41(1-2):106-122. PubMed ID: 37646421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 90-day prognostic value of serum cyclophilin A in traumatic brain injury.
    Jin HH; Mao TM; Bai ZQ; Chen Y; Ji HL; Jin Y
    Clin Chim Acta; 2018 Sep; 484():258-264. PubMed ID: 29885319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of tenascin-C concentrations in serum with outcome of traumatic brain injury in humans.
    Zhao YY; Lou L; Yang KC; Wang HB; Xu Y; Lu G; He HY
    Clin Chim Acta; 2017 Sep; 472():46-50. PubMed ID: 28732652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial.
    Hellewell SC; Mondello S; Conquest A; Shaw G; Madorsky I; Deng JV; Little L; Kobeissy F; Bye N; Bellomo R; Cooper DJ; Vallance S; Board J; Morganti-Kossmann MC
    Crit Care Med; 2018 Apr; 46(4):554-561. PubMed ID: 29278529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.
    Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S
    Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective pilot study on serum cleaved tau protein as a neurological marker in severe traumatic brain injury.
    Pandey S; Singh K; Sharma V; Pandey D; Jha RP; Rai SK; Chauhan RS; Singh R
    Br J Neurosurg; 2017 Jun; 31(3):356-363. PubMed ID: 28293977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitinase-3-Like Protein 1, Serum Amyloid A1, C-Reactive Protein, and Procalcitonin Are Promising Biomarkers for Intracranial Severity Assessment of Traumatic Brain Injury: Relationship with Glasgow Coma Scale and Computed Tomography Volumetry.
    Carabias CS; Gomez PA; Panero I; Eiriz C; Castaño-León AM; Egea J; Lagares A;
    World Neurosurg; 2020 Feb; 134():e120-e143. PubMed ID: 31606503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.